NCSS Launches a Full-Cycle R&D Center
We announce the opening of a full-cycle R&D center focused on the development of approaches for the synthesis of Active Pharmaceutical Ingredients (APIs) and the creation of finished dosage forms based on them, in line with the priorities of pharmaceutical manufacturing localization in the Russian Federation.
Full Development Cycle – From Concept to Industrial Implementation
The NCSS R&D center establishes an integrated scientific and technological platform that consolidates all key stages of drug development.
Development and optimization of synthetic routes for API production
Process scale-up from laboratory to pilot scale
Isolation, purification, and structural characterization of substances
Impurity profiling and control
Development and validation of analytical methods
Formulation development taking into account biopharmaceutical properties
Preparation of technology for industrial transfer
Comprehensive solution
Thus, NCSS offers a comprehensive solution enabling project execution without contractor fragmentation or technological risks, acting as a single project management center that includes economic evaluation, sourcing of required materials, and support across all regulatory processes.
NCSS Advantages
Strong scientific and analytical foundation
In-house expertise in method validation in compliance with GMP and ICH requirements
Highly qualified specialists with experience in organic synthesis, analytical chemistry, and physicochemical analysis
Broad capabilities to engage subcontractors for complex tasks and implementation of innovative methodologies
High flexibility in assembling project teams with rapid onboarding of required expertise tailored to specific projects
Extensive portfolio of high-tech equipment
R&D Center Capabilities
The NCSS R&D center is designed to execute projects of any complexity – from development of conventional small molecules to solving advanced scientific and technological challenges:
Development of synthetic routes
Development of stable dosage forms
Purification and isolation of difficult-to-obtain compounds
Addressing issues related to poor solubility, bioavailability, and stability of substances
Strategic Significance
Localization of the full development cycle is a strategically important direction for the pharmaceutical industry. The launch of the NCSS R&D center is part of a systemic effort to strengthen technological independence in the Russian Federation and reduce reliance on imported APIs.
Implementation of full-cycle projects within the country ensures supply chain resilience and technological sovereignty, contributes to reduced development timelines and faster time-to-market, enhances quality control across all lifecycle stages, mitigates economic and logistical risks, and creates a foundation for further development of the scientific and manufacturing base and long-term industry growth.